Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0990-2019

Drug recall · March 20, 2019

Oxybutynin Chloride Extended-Release Tablets USP 10 mg recall

Why: Failed Dissolution Specifications

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291-634-50) bottles, Rx Only Manufactured for: AvKARE, Inc. Pulaski, TN 38478

Lots / codes

Lots: a) 22738 Exp. 07/2020 and b) 22739 Exp. 07/2020

Quantity
a) 2947 and b) 3379
Company
AVKARE Inc., Pulaski, TN
Distribution
Nationwide.
Initiated
March 1, 2019 · Voluntary: Firm initiated
Classified
March 11, 2019
Reported
March 20, 2019
Ended
January 14, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Oxybutynin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.